ICD-10 Coding for Moderate Persistent Asthma(J20.9U, J44.9, J44.9U)

Explore the ICD-10 coding for moderate persistent asthma, including documentation requirements and coding tips for accurate billing.

Also known as:
Chronic AsthmaAsthma with Moderate Persistenceasthma moderate persistent
Related ICD-10 Code Ranges

Complete code families applicable to Moderate Persistent Asthma

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
J45.40Moderate persistent asthma, uncomplicated
J45.41Moderate persistent asthma with (acute) exacerbation
J45.42Moderate persistent asthma with status asthmaticus

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information

Essential facts and insights aboutModerate Persistent Asthma

Differential Codes

Alternative codes to consider when ruling out similar conditions

COPD with asthmaJ44.9
Moderate persistent asthma with status asthmaticusJ45.42
Moderate persistent asthma with (acute) exacerbationJ45.41

Documentation & Coding Risks

Avoid these common issues when documenting Moderate Persistent Asthma.

Failure to document exacerbation details.

Impact

Clinical: May lead to inadequate treatment planning., Regulatory: Non-compliance with documentation standards., Financial: Potential loss of reimbursement.

Mitigation

Use templates that prompt for exacerbation details., Regular training on documentation standards.

Using unspecified codes when specifics are available.

Impact

Reimbursement: May lead to lower reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of patient data.

Mitigation

Ensure documentation specifies 'moderate persistent' and any complications.

Exacerbation documentation

Impact

Inadequate documentation of exacerbation can lead to audit issues.

Mitigation

Ensure detailed documentation of symptoms and treatment changes.

Frequently Asked Questions